Liana Sadikova

Mrs. Liana Sadikova

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Kristen Laura KoppKristen Laura Kopp
Kristen Laura Kopp
LMLukas J. Motloch
Lukas J. Motloch
Michael LichtenauerMichael Lichtenauer
Michael Lichtenauer
EBElke Boxhammer
Elke Boxhammer
UHUta C. Hoppe
Uta C. Hoppe
NZNaufal Zagidullin
Naufal Zagidullin
Background: Increased mortality and occurrence of cardiovascular (CV) outcomes during hospitalization and in short-term follow-up for moderate to severe SARS-CoV-2 infection have been associated with male sex, yet data regarding long-term outcomes by sex and COVID-19 variant (Alpha, Delta, and Omicron) are limited. Methods: This prospective study of 4882 patients examines potential differences by sex in the occurrence of primary combined cardiovascular outcomes (CV death, CV hospitalization, myocardial infarction (MI), stroke, pulmonary embolism) as well as secondary outcomes (CV death, cardiovascular hospitalizations, myocardial infarction, stroke, pulmonary embolism) at 18-month follow-up after urgent hospitalization for SARS-CoV-2-associated pneumonia, as well as evaluating for differences during the three COVID-19 waves. Survival rate was analyzed for the entire cohort by sex and SARS-CoV-2 variant and adjusted for age using the multiple Kaplan–Meier method. To compare survival in groups of men and women for each wave, the Gehan–Wilcoxon test was applied with significance p < 0.05. Univariate Cox proportional hazards models were used to search for potential risk factors of CV death at 18-months follow-up separately for men and women in each COVID-19 wave. Results: Men had significantly higher 18-month CV mortality compared to women in the Delta wave (6.13% men vs. 3.62% women, p = 0.017). Although men had higher percentages of all other CV endpoints (excepting pulmonary embolism) at follow-up during the Delta wave, none were significant compared with women, except for the combined CV endpoint (16.87% men vs. 12.61% women, p = 0.017). No significant differences by sex in CV outcomes were seen during the Alpha and Omicron variants. Discrepancies in CV outcomes in demographical data and concomitant disease between the COVID-19 variants of concern existed. Conclusions: Higher male mortality and higher but non-significant incidences of CV outcomes occurred during the Delta wave of the COVID-19 pandemic, with the lowest incidence of CV outcomes observed during the Omicron variant.

25 June 2020 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
ILI. A. Lakman
I. A. Lakman
AAAlexander Agapitov
Alexander Agapitov
LSLiana Sadikova
Liana Sadikova
OCO. V. Chernenko
O. V. Chernenko
SNS. V. Novikov
S. V. Novikov
NZNaufal Zagidullin
Naufal Zagidullin
A new coronavirus infection (CVI) is a challenge to the medical system of the Russian Federation and requires precise flow forecasting to take the necessary measures on time. The article provides an overview of modern mathematical tools for predicting the course of CVI in the world. The created CVI forecasting project office allowed to determine the most effective analysis tools in the Russian Federation — the ARIMA, SIRD and Holt–Winters exponential smoothing models. Implementation of these models allows for prediction of short-term morbidity, mortality and survival of patients with an accuracy of 99 % both in the Russian Federation in general and in the regions. In addition, the distribution of CVI was characterized. Particularly, Moscow and Moscow region have the maximum spread of infection, and other regions are lagging behind in the dynamics of the incidence by 1–3 weeks. The obtained models allow us to predict the course of the disease in the regions successfully and take the necessary measures in a timely manner.

27 December 2023 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
GLG. Kh. Lasynova
G. Kh. Lasynova
ILIrina Lakman
Irina Lakman
DGDiana Gareeva
Diana Gareeva
AAAlexander Agapitov
Alexander Agapitov
LSLiana Sadikova
Liana Sadikova
NZNaufal Zagidullin
Naufal Zagidullin
Due to the large number of complications and decreased quality of life after coronavirus disease (COVID-19), physical and psychological rehabilitation of patients is relevant. However, the effectiveness of rehabilitation on endpoints has not yet been demonstrated.Aim. To determine the effectiveness of different rehabilitation options in hospitalized patients with COVID-19 on the development of long-term adverse cardiovascular events 1 year after discharge.Material and methods. In a single-center, non-randomized observational study, 3 groups of patients were formed after hospitalization with COVID-19: I — with telemedicine rehabilitation (n=118), II — with rehabilitation in a specialized department (n=46) and III — without rehabilitation (n=175). After 1-year followup, groups were compared regarding following endpoints: cardiovascular mortality, myocardial infarction, stroke, pulmonary embolism, atrial fibrillation and cardiovascular hospitalization. Propensity score matching analysis was used to optimize differences between comparison groups.Results. Rehabilitation after hospitalization of patients with COVID-19, both in the hospital and remotely for 1 year, helps to reduce cardiovascular hospitalization rate. In addition, remote rehabilitation reduces cardiovascular mortality.Conclusion. Both rehabilitation options reduce the incidence of cardiovascular hospitalization compared to no rehabilitation.

25 January 2024 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
DGDiana Gareeva
Diana Gareeva
ILIrina Lakman
Irina Lakman
AAAlexander Agapitov
Alexander Agapitov
LSLiana Sadikova
Liana Sadikova
PDParuir A. Davtian
Paruir A. Davtian
КЛКаюмова Валерия Леонидовна
Каюмова Валерия Леонидовна
Background. During the pandemic of coronavirus infection (COVID-19) caused by a virus SARS-CoV-2 there has been significant variability in symptoms of the disease over time, severity of the course and in particular hospital mortality. Several SARS-CoV-2 variants have been identified such as Alpha, Delta, Omicron and others. Aim. To investigate the hospital mortality in patients with different strain variants during the period from April 2020 to April 2022. All included patients had moderate to severe COVID-19-associated pneumonia requiring hospitalization. Materials and methods. In this retrospective, conclusive, non-randomized, non-controlled study 4854 clinical records of hospitalized patients with Alpha (n=2400, April – December 2020), Delta (n=1722, 2021) and Omicron (n=627, January – April 2022) variants were investigated. Results. Hospital mortality is 6% in Alpha variant patients (6%), 5.7% in Delta and significantly lower in Omicron (1.5%; p0,001). Cardiovascular disease (arterial hypertension, coronary heart disease, chronic heart failure), diabetes mellitus and chronic kidney disease were risk factors for death in Alpha and Delta, but not in Omicron. There was also a significant decrease in the duration of hospitalization with strains Delta [7 days (5; 9)] and Omicron [7 (5; 11)] compared with Alpha [11 (9; 13); p0,001], and differences in factors the risk of mortality between the tested COVID variants. Conclusion. Thus, differences in mortality and risk factors for death between COVID-19 variants could be shown in our cohort.

30 December 2023 in Yakut Medical Journal
Verified
Journal Article
Closed access
ILIrina Lakman
Irina Lakman
Venera TimiryanovaVenera Timiryanova
Venera Timiryanova
AAAlexander Agapitov
Alexander Agapitov
LSLiana Sadikova
Liana Sadikova
BIB.T. Idrisov
B.T. Idrisov
DGDiana Gareeva
Diana Gareeva
Accumulating evidence indicates a high prevalence of long-term negative consequences of COVID-19. Their final assessment is possible only after their complete disappearance, which, given the ongoing registration of negative assessments of the health status of some hospitalized COVID-19 patients, is impossible in the near future. Taking this into account, further study of post-Covid consequences in dynamics is relevant. The purpose of the study was to determine the quality of life and health of patients in the long-term period (24 months) after hospitalization for COVID-19-associated pneumonia. Material and methods. The study was conducted on data from 158 patients with moderate and severe severity who were hospitalized during the first wave of coronavirus infection in the period 09/01/2020-11/30/2020. To assess the quality of life in the post-Covid period the VR-12 questionnaire was used. The study involved conducting structural and frequency analysis, assessing the consistency of answers to the questionnaire using Cronbach's alpha and the chi-square test, calculating the nonparametric Spearman rank correlation coefficient, and non-serial correlation coefficients. To identify factors influencing health assessments, a linear regression model was built. Ordered logistic regression was estimated to identify factors influencing the distribution of responses to additional questions. Results. The analysis showed an insignificant difference between the physical component summary (PCS) and mental component summary (MCS) of the respondents. A connection was found between age and the risk of deterioration in self-esteem of health. It was possible to identify a significant difference in the self-assessment of the quality of physical and mental health in men and women, taking into account adjustment for age, two years after suffering from pneumonia, and also to substantiate the non-significance of RDS during hospitalization, given the significance of a high percentage of lung damage for the lower self-assessment of health of persons who had suffered coronavirus infection of moderate and severe severity. Conclusion. The results are largely consistent with studies conducted in other countries, indicating an uneven change in post-Covid consequences and emphasizing the importance of individual recovery programs taking into account the severity of the disease, age and gender of patients. Keywords: post-Covid consequences, long-COVID, VR-12, mental health index, physical component summary, mental component summary.

1 November 2024 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
DGDiana Gareeva
Diana Gareeva
ILIrina Lakman
Irina Lakman
АААлександр Александрович Агапитов
Александр Александрович Агапитов
LSLiana Sadikova
Liana Sadikova
Venera TimiryanovaVenera Timiryanova
Venera Timiryanova
NZNaufal Zagidullin
Naufal Zagidullin
Highlights We propose serum biomarkers as risk assessment tools for patients with COVID-19. J-waves are a common ECG finding, detected in 4–6% of the population, and are a risk factor for ventricular tachycardia and mortality in COVID-19 patients. Aim. To evaluate the prognostic potential of a combination of cardiac-specific biomarkers and ECG J-waves regarding long-term mortality and cardiovascular complications after discharge in patients with COVID-19-associated pneumonia.Methods. Serum biomarkers sST2, VCAM-1 and hs-TnI were assessed at admission in 254 patients hospitalized with COVID-19-associated pneumonia. ECGs on admission were analyzed for the presence of J waves. Clinical and laboratory characteristics of patients, as well as biomarker concentrations and the presence of J-waves on the ECG, were correlated with mortality and cardiovascular complications after discharge at 12 months [FU: 347 (310, 449) days]. Cox proportional hazards models were used to identify predictors of the risk of mortality and the composite endpoint up to one year after discharge.Results. A high level of VCAM-1 was a significant predictor of the risk of a combined endpoint (MI, stroke, pulmonary embolism, sudden death): HR = 1.049, CI 95%: 1.016–1.083; and high sST2 level was a significant predictor of the risk of both death (HR = 1.006, CI 95%: 1.004–1.007) and the composite endpoint (HR = 1.005, CI 95%: 1.003–1.006). In the generalized multivariate model, when other influencing factors were combined, the presence of a J-wave on the ECG during hospitalization was statistically insignificant (p > 0.5) for predicting sudden death up to a year after discharge.Conclusion. In hospitalized COVID-19 survivors, elevated hsTnI and sST2 levels on admission were strong predictors of CV events during long-term follow-up. On the other hand, the significance of the J-wave on the ECG in predicting long-term CV events remains borderline.